FUGE grants to research groups at the Institute for Cancer Research
The Board of FUGE (Functional Genomics in Norway) decided in a meeting on the 8th of March 2004 to grant NOK 54.2 mill to support research projects in the fields of medicine and basal biology including bioinformatics.
On a meeting on the 3rd of May it was decided to support seven research projects. Three of the seven grants went to research groups at the Institute for Cancer Research at the Norwegian Radium Hospital.
From major journals, first or last author from the Institute for Cancer Research
Hauge A, Gaustad JV, Huang R, Simonsen TG, Wegner CS, Andersen LMK, Rofstad EK(2019) DCE-MRI and Quantitative Histology Reveal Enhanced Vessel Maturation but Impaired Perfusion and Increased Hypoxia in Bevacizumab-Treated Cervical Carcinoma Int J Radiat Oncol Biol Phys(in press) DOI 10.1016/j.ijrobp.2019.03.002, PubMed 30858145
Öjlert ÅK, Halvorsen AR, Nebdal D, Lund-Iversen M, Solberg S, Brustugun OT, Lingjaerde OC, Helland Å(2019) The immune microenvironment in non-small cell lung cancer is predictive of prognosis after surgery Mol Oncol(in press) DOI 10.1002/1878-0261.12475, PubMed 30854794
Steen CB, Leich E, Myklebust JH, Lockmer S, Wise JF, Wahlin BE, Østenstad B, Liestøl K, Kimby E, Rosenwald A, Smeland EB, Holte H, Lingjærde OC, Brodtkorb M(2019) A clinico-molecular predictor identifies follicular lymphoma patients at risk of early transformation after first-line immunotherapy Haematologica(in press) DOI 10.3324/haematol.2018.209080, PubMed 30846496